menu

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

    FDA medical oncologists discuss the approval of l-glutamine to reduce the acute complications of sickle cell disease.
    • Overview

      FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

      Released August 17, 2017

    Facebook Comments

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.